News

Lewis will be responsible for the finance, accounting, IT, human resources and facilities functions and also becomes part of the company’s executive management team which directs all aspects

A total of 524 non-professional adult AD caregivers, including those of mild, moderate and severe AD patients, were surveyed in September 2010. Majority (67%) of AD caregivers surveyed

The companies collectively have over 20 facilities, 140 printing presses, 1,900 associates globally. The partnership agreement is expected to provide a strong basis for an intensive operational cooperation

Under the agreement, BioLineRx acquires all rights to develop, sub-license and commercialise the compound. BioLineRx will cover all future costs of the program. Santhera will receive 22% to

As part of the realignment, around 10 and 15 employees will move from Birmingham to Durham. This will result in the elimination of eight jobs, which will be

Under the brand name Conbriza, the drug will also be marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain. Viviant, a selective

Nefecon is an oral small molecule product which downregulates the inflammatory process in the kidneys. Nefecon is being co-developed by Pharmalink and Archimedes Pharma under a partnership agreed

The grant is in response to the solicitation ‘Recovery Act Limited Competition: NIH Director’s Opportunity for Research in Five Thematic Areas (RC4),’ funded by the American Recovery and

The agreement allows Lundbeck to gain access to Genmab’s antibody creation and development capabilities, including its fully automated pre-clinical antibody screening and characterisation capabilities and its proprietary stabilised